现金及等价物 更改
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Agios Pharmaceuticals USD 89.13M 3.58M 2025-12
ALKERMES USD 388.57M 227.88M 2025-12
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Amgen USD 9.13B 316M 2025-12
Anika Therapeutics USD 57.48M 509K 2025-12
Arrowhead Research USD 201.64M 112.94M 2025-12
Biogen USD 3.01B 854.3M 2025-12
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Cara Therapeutics USD 21.42M 770K 2025-09
Cipla INR 7.96B 39.9M 2025-09
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 90.6M 83.14M 2025-12
CSL USD 2.16B 633M 2025-06
Cytokinetics USD 122.52M 102.95M 2025-12
Enanta Pharmaceuticals USD 37.44M 5.14M 2025-12
Gilead Sciences USD 7.33B 2.19B 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Grifols EUR 979.78M 334.84M 2024-12
Halozyme Therapeutics USD 133.82M 285.84M 2025-12
Heron Therapeutics USD 43.07M 26.55M 2025-09
Insmed USD 510.44M 175.68M 2025-12
Ligand Pharmaceuticals USD 174.93M 489.59M 2025-12
MannKind USD 74.88M 52.51M 2025-12
Merck EUR 2.25B 1.08B 2025-09
Moderna USD 2.6B 1.46B 2025-12
Neurocrine Biosciences USD 713M 372.8M 2025-12
Novartis USD 9.56B 2.9B 2025-09
Pfizer USD 1.34B 295M 2025-09
Sanofi EUR 7.66B 1.25B 2025-12
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12